The 2020 Pete Frates Memorial 5K Run/Walk/Wheel will be held virtually and benefit the Healey Center for ALS at Mass General.
Healey Center News & Events
The Sean M. Healey and AMG Center for ALS at Massachusetts General Hospital is proud to offer the Healey Scholars Program, which funds young investigators researching treatments for people living with ALS.
The National Academy of Medicine has elected 100 new members, including Merit Cudkowicz, MD, MSc, Chief of Neurology and Director of the Healey Center for ALS at Mass General.
An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, has now demonstrated the potential to also prolong patient survival.
Sabrina Paganoni, MD, PhD, co-director, MGH Neurological Clinical Research Institute of Massachusetts General Hospital, was awarded an MDA research grant totaling $500,000 over three years to continue development of the first Platform Trial for ALS.
In addition to helping staff boost their strength and resiliency, Meekins also helps ALS patients cope with their diagnosis, care and end-of-life decisions.
AMX0035 is the first investigational therapy to demonstrate statistically significant benefit in people with ALS since approved therapies riluzole and edaravone.
With the help of donors including the Byrne Family, the Judith and Jean Pape Adams Foundation and the Cullen Education and Research Fund, these new young investigators will have the opportunity to play a central role in breaking down current barriers, accelerating the translation of research findings into care, and expanding treatment access to innovative and personalized therapeutic trials.
First Participants Enrolled in the Groundbreaking Trial Led by the Sean M. Healey & AMG Center for ALS at Mass General
As the first ever platform trial for ALS, the HEALEY ALS Platform Trial is testing three proposed drug regimens and will add two more over the next several months.
New studies focus on the SOD1 gene in ALS.
Transforming Medicine Through Innovation
Research at Massachusetts General Hospital integrates the full spectrum of "bench to bedside" discovery. Laboratory scientists work collaboratively with clinicians to make discoveries and turn them into treatments, diagnostics and devices that improve our quality of life.